Related Experiment Video
Updated: Jun 25, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review
Rikke V Nielsen1, Valentin Fuster2, Henning Bundgaard3
1Department of Medical Science, Novo Nordisk Foundation, Hellerup, Denmark; Department of Cardiothoracic Anesthesiology, Rigshospitalet University Hospital Copenhagen, Copenhagen, Denmark.
Insights
Cardiovascular disease (CVD) is a major global health issue. Early detection of subclinical atherosclerosis using precision medicine offers a chance to prevent heart attacks and strokes, shifting focus from late-stage management to early intervention.
Area of Science:
- Cardiology
- Preventive Medicine
- Biomarkers
Background:
- Cardiovascular disease (CVD) is the leading cause of global mortality.
- Atherosclerosis underlies most CVD cases and develops over decades.
- Early detection of subclinical atherosclerosis is crucial for prevention.
Purpose of the Study:
- To advocate for a paradigm shift in CVD management.
- To explore early detection of subclinical atherosclerosis.
- To investigate the role of precision medicine in CVD prevention.
Main Methods:
- Reviewing the pathophysiology of atherosclerosis.
- Identifying opportunities for early intervention.
- Proposing the use of imaging and circulating biomarkers.
Main Results:
- Atherosclerosis begins in early life, presenting a window for prevention.
- Current strategies focus on late-stage management, missing prevention opportunities.
- Precision medicine holds potential for earlier and more effective detection.
Conclusions:
- A paradigm shift towards early detection of subclinical atherosclerosis is necessary.
- Precision medicine approaches can identify atherosclerosis in its early stages.
- Further research is needed to confirm cost-effectiveness of early detection strategies.
Abstract:
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide and challenges the capacity of health care systems globally. Atherosclerosis is the underlying pathophysiological entity in two-thirds of patients with CVD. When considering that atherosclerosis develops over decades, there is potentially great opportunity for prevention of associated events such as myocardial infarction and stroke. Subclinical atherosclerosis has been identified in its early stages in young individuals; however, there is no consensus on how to prevent progression to symptomatic disease. Given the growing burden of CVD, a paradigm shift is required-moving from late management of atherosclerotic CVD to earlier detection during the subclinical phase with the goal of potential cure or prevention of events. Studies must focus on how precision medicine using imaging and circulating biomarkers may identify atherosclerosis earlier and determine whether such a paradigm shift would lead to overall cost savings for global health.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Overview of Systemic Arteries
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hypertension and Regulation of Blood Pressure
Pre-Procedural Guidelines for Assessing Blood Pressure